ZAG has also been shown to suppress the growth of oral and pancreatic cancer by downregulating cyclin-dependent kinase 1 gene and inducing mesenchymal-to-epithelial transdifferentiation, respectively (71, 72). This evidence concerns the gene CDK1 and familial pancreatic carcinoma.